Janetzky相关文献与解析，生知库 | 链接生命科学的每一步

Janetzky, Markus; Geist, Norman; Schulze, Sabrina; Rückert, Henriette; Gatzemeyer, Kimani; Palm, Gottfried J; Berndt, Leona; Girbardt, Britta; Weis, Daniel; Menyes, Ina; Welsch, Norma; Schweder, Thomas; Dörr, Mark; Kemnitz, Stefan; Bornscheuer, Uwe T; Delcea, Mihaela; Lammers, Michael

微生物学

细胞生物学

发表日期：2026

文献求助收藏

Distribution and diversity of classical deacylases in bacteria

细菌经典脱酰酶的分布和多样性

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-024-53903-0

Leonie G Graf, Carlos Moreno-Yruela, Chuan Qin, Sabrina Schulze, Gottfried J Palm, Ole Schmöker, Nancy Wang, Dianna M Hocking, Leila Jebeli, Britta Girbardt, Leona Berndt, Babett Dörre, Daniel M Weis, Markus Janetzky, Dirk Albrecht, Daniela Zühlke, Susanne Sievers, Richard A Strugnell, Christian A O

微生物学

发表日期：2024

文献求助收藏

Acetyl-CoA synthetase activity is enzymatically regulated by lysine acetylation using acetyl-CoA or acetyl-phosphate as donor molecule

乙酰辅酶 A 合成酶活性受赖氨酸乙酰化酶调控，以乙酰辅酶 A 或乙酰磷酸为供体分子

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-024-49952-0

Chuan Qin, Leonie G Graf, Kilian Striska, Markus Janetzky, Norman Geist, Robin Specht, Sabrina Schulze, Gottfried J Palm, Britta Girbardt, Babett Dörre, Leona Berndt, Stefan Kemnitz, Mark Doerr, Uwe T Bornscheuer, Mihaela Delcea, Michael Lammers

表观遗传

发表日期：2024

文献求助收藏

Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly

一项为期6个月的非干预性研究，对194名精神分裂症门诊患者进行了自然随访，评估了每月一次服用阿立哌唑的疗效，并测量了他们的症状、功能和生活质量缓解情况。

期刊:npj Schizophrenia

影响因子:4.1

doi:10.1038/s41537-023-00405-5

Correll, Christoph U; Brieden, Andreas; Janetzky, Wolfgang

BPRS domains, items and subgroups analyses, and CGI-I ratings in pooled data from non-interventional studies of aripiprazole once-monthly in schizophrenia (REACT study)

BPRS 领域、项目和亚组分析以及 CGI-I 评级在阿立哌唑每月一次治疗精神分裂症的非干预性研究（REACT 研究）的汇总数据中

期刊:BMC Psychiatry

影响因子:3.6

doi:10.1186/s12888-023-04651-w

Schöttle, Daniel; Janetzky, Wolfgang; Therrien, Francois; Wiedemann, Klaus

Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)

改善精神分裂症患者功能：每月一次阿立哌唑的真实世界疗效（REACT 研究）

期刊:BMC Psychiatry

影响因子:3.6

doi:10.1186/s12888-023-04893-8

Oluboka, Oloruntoba; Clerzius, Guerline; Janetzky, Wolfgang; Schöttle, Daniel; Therrien, François; Wiedemann, Klaus; Roy, Marc-André

Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies

REACT 研究：阿立哌唑每月一次给药方案的真实世界疗效：两项非干预性研究的汇总分析

期刊:European Psychiatry

影响因子:6.7

doi:10.1192/j.eurpsy.2022.27

Schöttle, Daniel; Clerzius, Guerline; Janetzky, Wolfgang; Oluboka, Oloruntoba; Roy, Marc-André; Therrien, François; Wiedemann, Klaus

发表日期：2022

文献求助收藏

The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index

在德国开展的一项多中心、前瞻性、非对照、开放标签队列研究中，使用长效阿立哌唑的疗效：一项关于全球功能评估和世界卫生组织幸福指数的报告

期刊:BMC Psychiatry

影响因子:3.6

doi:10.1186/s12888-020-02488-1

Schöttle, Daniel; Janetzky, Wolfgang; Luedecke, Daniel; Beck, Elmar; Correll, Christoph U; Wiedemann, Klaus

发表日期：2020

文献求助收藏

Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

每月一次阿立哌唑治疗既往接受过口服阿立哌唑治疗的精神分裂症患者的疗效：一项为期6个月的真实世界非干预性研究

期刊:BMC Psychiatry

影响因子:3.6

doi:10.1186/s12888-018-1946-x

Schöttle, Daniel; Janetzky, Wolfgang; Luedecke, Daniel; Beck, Elmar; Correll, Christoph U; Wiedemann, Klaus

Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

更正：每月一次阿立哌唑治疗预先接受口服阿立哌唑治疗的精神分裂症患者的疗效：一项为期6个月的真实世界非干预性研究

期刊:BMC Psychiatry

影响因子:3.6

doi:10.1186/s12888-018-1968-4

Schöttle, Daniel; Janetzky, Wolfgang; Luedecke, Daniel; Beck, Elmar; Correll, Christoph U; Wiedemann, Klaus

AcuB senses cellular energy charge to coordinate acetyl-CoA synthesis in bacteria

AcuB感知细胞能量电荷，从而协调细菌中乙酰辅酶A的合成。

Distribution and diversity of classical deacylases in bacteria

细菌经典脱酰酶的分布和多样性

Acetyl-CoA synthetase activity is enzymatically regulated by lysine acetylation using acetyl-CoA or acetyl-phosphate as donor molecule

乙酰辅酶 A 合成酶活性受赖氨酸乙酰化酶调控，以乙酰辅酶 A 或乙酰磷酸为供体分子

Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly

一项为期6个月的非干预性研究，对194名精神分裂症门诊患者进行了自然随访，评估了每月一次服用阿立哌唑的疗效，并测量了他们的症状、功能和生活质量缓解情况。

BPRS domains, items and subgroups analyses, and CGI-I ratings in pooled data from non-interventional studies of aripiprazole once-monthly in schizophrenia (REACT study)

BPRS 领域、项目和亚组分析以及 CGI-I 评级在阿立哌唑每月一次治疗精神分裂症的非干预性研究（REACT 研究）的汇总数据中

Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)

改善精神分裂症患者功能：每月一次阿立哌唑的真实世界疗效（REACT 研究）

Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies

REACT 研究：阿立哌唑每月一次给药方案的真实世界疗效：两项非干预性研究的汇总分析

The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index

在德国开展的一项多中心、前瞻性、非对照、开放标签队列研究中，使用长效阿立哌唑的疗效：一项关于全球功能评估和世界卫生组织幸福指数的报告

Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

每月一次阿立哌唑治疗既往接受过口服阿立哌唑治疗的精神分裂症患者的疗效：一项为期6个月的真实世界非干预性研究

Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

更正：每月一次阿立哌唑治疗预先接受口服阿立哌唑治疗的精神分裂症患者的疗效：一项为期6个月的真实世界非干预性研究